A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma
Background. Inflammation plays a key role in cancer. In the current study, we proposed a novel inflammation-based stage, named I stage, for patients with resectable esophageal squamous cell carcinoma (ESCC). Methods. Three hundred and twenty-three patients with resectable ESCC were enrolled in the c...
Saved in:
Main Authors: | Peng-Cheng Chen (Author), Ji-Feng Feng (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
by: Rutao Li, et al.
Published: (2022) -
Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II-III Esophageal Squamous Cell Carcinoma
by: Huiping Zhu MD, et al.
Published: (2022) -
Surveillance for metachronous cancers after endoscopic resection of esophageal squamous cell carcinoma
by: Ryu Ishihara
Published: (2024) -
Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
by: Linghong Kong, et al.
Published: (2023) -
Strategies for the Endoscopic Management and Post-Resection Treatment of Superficial Esophageal Squamous Cell Carcinoma
by: Hyun Ho Choi
Published: (2024)